Roundtable Discussion; The Future of Mineral Sands. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksVpc Specialty Regulatory News (VSL)

Share Price Information for Vpc Specialty (VSL)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 48.00
Bid: 47.80
Ask: 48.00
Change: 0.00 (0.00%)
Spread: 0.20 (0.418%)
Open: 0.00
High: 0.00
Low: 0.00
Prev. Close: 48.00
VSL Live PriceLast checked at -
VPC Specialty Lending Investments is an Investment Trust

To generate an attractive total return for shareholders consisting of dividend income and capital growth through investments in specialty lending opportunities.

Find out More

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Kepler Trust Intelligence: New Research

15 Oct 2019 14:00

RNS Number : 9455P
VPC Specialty Lending Invest. PLC
15 October 2019
 

VPC Specialty Lending Investments: New research

15/10/2019

VSL offer a yield of over 10% from an asset-backed portfolio of loans…

Read more

VPC Specialty Lending Investments (VSL) lends to sponsor-backed alternative lending companies, using its specialist knowledge of the sector to generate an average coupon of 11.84% from asset-backed loans, with low impairment rates and strong performance in stress-tests. The 8p a year dividend, paid quarterly, is now almost 100% covered by interest income and fully covered by NAV total returns. The yield is 10.2% on the current share price, with the trust trading on a 14.8% discount.

VSL acts as a 'lender to lenders', with its loans secured against the loans made by the portfolio companies and with significant first loss protection provided by the borrowers. These are primarily consumer loans, to US, UK and Latin American borrowers. There are also loans made to SMEs, but these make up only 15% of the portfolio. The loans are structured in such a way that VSL monitors the health of the investee's balance sheet on a monthly basis, and can demand further capitalisation if impairments rise, or take control of the loan book to pay back their investment in extreme circumstances.

The company is something of a turnaround story. When launched, it invested in unsecured marketplace loans and securitisation in addition to a portfolio of balance sheet loans, but after impairments in this new field were higher than expected refocused the company to a balance-sheet only model more in line with the expertise of the manager, Victory Park Capital.

VPC is a specialist lender to sponsor backed companies, in particular fintech. It operates at scale, with VPC having committed and invested more than $7bn across more than 50 companies in the financial services sector. VSL, at £297m net assets, can therefore participate in much larger deals negotiated by the manager, which are allocated largely pro rata across its various funds and accounts.

The portfolio is concentrated, with 43% in the top four positions, although underlying the 22 total debt investments are over 1.8 million individual loans. On a look-through basis, the total gearing is 43%, with the company having drawn down a facility worth roughly 16% to lever up its largest investment, in Elevate Credit. Elevate Credit is now a public company having IPO'd on the NYSE in 2018 and is the manager's longest standing portfolio company, with a lending relationship of nearly a decade and consistently strong performance.

Click here to read the full report

 

Visit http://www.trustintelligence.co.uk/investor for more high quality independent investment trust research.

Not for distribution, directly or indirectly, in or into the United States or any jurisdiction in which such distribution would be unlawful.

Important information

VPC Specialty Lending Investments is a client of Kepler Trust Intelligence. This material should be considered a marketing communication, and is not independent research.

Kepler Partners is not authorised to make recommendations to Retail Clients. This report is based on factual information only, and is solely for information purposes only and any views contained in it must not be construed as investment or tax advice or a recommendation to buy, sell or take any action in relation to any investment.

This report has been issued by Kepler Partners LLP solely for information purposes only and the views contained in it must not be construed as investment or tax advice or a recommendation to buy, sell or take any action in relation to any investment. If you are unclear about any of the information on this website or its suitability for you, please contact your financial or tax adviser, or an independent financial or tax adviser before making any investment or financial decisions.

The information provided on this website is not intended for distribution to, or use by, any person or entity in any jurisdiction or country where such distribution or use would be contrary to law or regulation or which would subject Kepler Partners LLP to any registration requirement within such jurisdiction or country. Persons who access this information are required to inform themselves and to comply with any such restrictions. In particular, this website is exclusively for non-US Persons. The information in this website is not for distribution to and does not constitute an offer to sell or the solicitation of any offer to buy any securities in the United States of America to or for the benefit of US Persons.

This is a marketing document, should be considered non-independent research and is subject to the rules in COBS 12.3 relating to such research. It has not been prepared in accordance with legal requirements designed to promote the independence of investment research.

No representation or warranty, express or implied, is given by any person as to the accuracy or completeness of the information and no responsibility or liability is accepted for the accuracy or sufficiency of any of the information, for any errors, omissions or misstatements, negligent or otherwise. Any views and opinions, whilst given in good faith, are subject to change without notice.

This is not an official confirmation of terms and is not to be taken as advice to take any action in relation to any investment mentioned herein. Any prices or quotations contained herein are indicative only.

Kepler Partners LLP (including its partners, employees and representatives) or a connected person may have positions in or options on the securities detailed in this report, and may buy, sell or offer to purchase or sell such securities from time to time, but will at all times be subject to restrictions imposed by the firm's internal rules. A copy of the firm's conflict of interest policy is available on request.

Past performance is not necessarily a guide to the future. The value of investments can fall as well as rise and you may get back less than you invested when you decide to sell your investments. It is strongly recommended that Independent financial advice should be taken before entering into any financial transaction.

PLEASE SEE ALSO OUR TERMS AND CONDITIONS

Kepler Partners LLP is a limited liability partnership registered in England and Wales at 9/10 Savile Row, London W1S 3PF with registered number OC334771.

Kepler Partners LLP is authorised and regulated by the Financial Conduct Authority.

 

 

 

About this service

Kepler Trust Intelligence for private investors is not just another news and research website. Our aim is to create a library of high quality investment strategy research, fund analysis and useful guides for private investors, all written in-house by experienced analysts on the investment companies team at Kepler Partners.

We are focused entirely on investment trusts, however we believe that it helps to understand them better if they are placed on a level playing field with OEICs, so you will see comparisons between the two in these pages often.

 

Our content falls into three categories;

Investment strategy articles are designed to highlight opportunities and developments which are of interest to investment trust investors, positive or negative.

Fund research focuses on individual trusts, examining them in detail to create a snapshot picture which you can use to decide whether or not you want to invest in them.

Educational output is split into simple guides, designed to help beginners understand how investment trusts work, and more complex guides to sectors, regions and strategies which may be of interest to investors.

We do not produce massive amounts of research. Our focus is on quality, not quantity, so we are unlikely to publish more than four or five articles in a given week. For this reason we recommend that you join our mailing list, and we'll send you an email once a week alerting you to what's new on the site. We won't sell your details, and we won't spam you with useless updates.

 

How are we funded?

Kepler Trust Intelligence is funded entirely by the providers of investment trusts, and is made available freely to any person (professional or private individual) who wants to access it. We clearly disclose all of our relationships, but our research is either paid for directly by specific trusts and their boards, or more generally by the larger asset management groups who pay to have adverts and advertorial. As a result, all of our research should be considered "non-independent" and readers should consider it as marketing.

All of our content is freely available to anyone. We run two versions of the site - one for professionals and one for private investors. The professional site requires readers to volunteer the name of the company they work for and the city / region - so that from a compliance perspective we can be satisfied that all readers really are a professional.

 

We provide information, not advice

While we hope that you find the research we publish useful, and we believe it will help you to make a more informed decision, but we must of course stress that none of the research published here constitutes a recommendation, or advice, and you should not think that - just because we've published a report on a trust - we believe that trust is a 'buy'. Please read our terms and conditions.

 

If you want to manage your own investments we hope that this website is a useful source of information which helps you to do that, however if you are in any doubt, you should speak to a financial adviser.

 

Pascal Dowling

 

Kepler Partners

END

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
NRAFFWFFIFUSEFS
Date   Source Headline
2nd May 20244:27 pmRNSNotice of AGM
24th Apr 20247:00 amRNSAnnual Financial Report
22nd Apr 20247:00 amRNSNet Asset Value(s)
17th Apr 20244:30 pmRNSInitial Return of Capital Exchange Ratio
9th Apr 20247:00 amRNSInitial Return of Capital through B Share Scheme
5th Apr 202411:23 amRNSResult of General Meeting
15th Mar 20247:00 amRNSPublication of circular relating to B share scheme
8th Mar 20243:00 pmRNSNet Asset Value(s)
22nd Feb 20248:54 amRNSReplacement - Dividend Declaration
22nd Feb 20247:00 amRNSDividend Declaration
7th Feb 20249:00 amRNSNet Asset Value(s)
17th Jan 20247:00 amRNSNet Asset Value(s)
8th Dec 20237:00 amRNSNet Asset Value(s)
17th Nov 20237:00 amRNSDividend Declaration
13th Nov 20237:00 amRNSNet Asset Value and Monthly Report
5th Oct 20237:00 amRNSNet Asset Value and Monthly Report
29th Sep 20237:00 amRNSHalf-year Report
6th Sep 20237:00 amRNSNet Asset Value and Monthly Report
24th Aug 20237:00 amRNSDividend Declaration
8th Aug 20231:21 pmRNSNet Asset Value and Monthly Report
13th Jul 202311:45 amRNSNet Asset Value(s) and Monthly Report
26th Jun 20237:00 amRNSDividend Declaration
23rd Jun 20235:08 pmRNSResult of AGM
12th Jun 20235:31 pmRNSResult of Meeting
7th Jun 20237:00 amRNSNet Asset Value(s)
31st May 20231:26 pmRNSDirectorate Change and Notice of AGM
16th May 20232:58 pmRNSCircular containing a Notice of General Meeting
11th May 202310:07 amRNSNet Asset Value(s)
28th Apr 20237:00 amRNSAnnual Financial Report
11th Apr 20235:33 pmRNSHolding(s) in Company
6th Apr 20237:00 amRNSNet Asset Value(s)
7th Mar 20237:00 amRNSNet Asset Value(s)
22nd Feb 20237:00 amRNSDividend Declaration
10th Feb 20237:00 amRNSNet Asset Value(s)
12th Jan 20237:00 amRNSNet Asset Value(s)
22nd Dec 20227:00 amRNSProposed Managed Wind-Down
8th Dec 20227:00 amRNSNet Asset Value(s)
7th Dec 20224:01 pmRNSReceipt of Requisition Notice
30th Nov 20227:00 amRNSDividend Declaration
8th Nov 20227:00 amRNSNet Asset Value(s)
11th Oct 202211:13 amRNSHolding(s) in Company
30th Sep 20227:00 amRNSNet Asset Value(s)
29th Sep 20227:00 amRNSHalf-year Report
31st Aug 20227:00 amRNSNet Asset Value(s)
25th Aug 20227:00 amRNSDividend Declaration
1st Aug 20227:00 amRNSNet Asset Value(s)
30th Jun 20227:00 amRNSNet Asset Value(s)
14th Jun 20227:00 amRNSDividend Declaration
13th Jun 20224:35 pmRNSResult of AGM
8th Jun 20227:00 amRNSNet Asset Value(s)

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.